HF
PHIO icon

HRT Financial’s Phio Pharmaceuticals PHIO Stock Holding History

HRT Financial’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42K Buy
+34,732
New +$39.6K ﹤0.01% 3472
2025
Q1 		– Sell
-42,338
Closed -$76K – 3196
2024
Q4 		$76K Buy
+42,338
New +$115K ﹤0.01% 2074
2022
Q4 		– Sell
-169
Closed -$10K – 2978
2022
Q3 		$10K Buy
+169
New +$12.8K ﹤0.01% 2537

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HRT Financial's PHIO Position: Q1 2026 in Review

HRT Financial opened a new position in Phio Pharmaceuticals (PHIO) in Q1 2026: 34,732 shares worth $42K. The stake represents ﹤0.01% of the portfolio and ranks #3472 among its holdings. This is a return to the name: HRT Financial previously reported a position in PHIO as recently as Q4 2024.

HRT Financial first reported a position in PHIO in Q3 2022 and has held it in 3 quarters since. The position peaked at $76K in Q4 2024. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • HRT Financial held 34,732 shares of Phio Pharmaceuticals worth $42K as of Q1 2026.
  • Phio Pharmaceuticals was a new HRT Financial position in Q1 2026.
  • Phio Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3472 holding.
  • HRT Financial first reported a position in Phio Pharmaceuticals in Q3 2022 and has held it in 3 quarters since.
  • HRT Financial's Phio Pharmaceuticals position peaked at $76K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.